A PROVEN PLATFORM.
QUALITY OUTCOMES.
Numerous clinical studies demonstrate what these leading centers already know: that the CyberKnife’s precise treatment delivery safely allows to expand radiosurgery indications.
Page 2 of 3
CASE STUDY
Recurrent Multiple Myeloma at Clivius & C1
CyberKnife® treatments, with sub-millimeter accuracy and highly conformal dosimetry, was the only reasonable option to control the patient’s tumor without causing undue radiation-induced toxicity.
CASE STUDY
Posterior Fossa Renal Cell Metastasis
Due to the tumor location, stereotactic radiosurgery (SRS) was indicated in favor of surgery. The patient proactively inquired six months prior regarding the possibility of CyberKnife® treatment should she develop recurrent disease in the lung or brain. SRS is a well recognized technique for the treatment of cerebellar renal cell carcinoma metastases.
CASE STUDY
Perineal Relapse of Prostate Carcinoma
The use of the CyberKnife System allows a clinician to perform accurate treatment because of its capability to track the tumor throughout treatment.
CASE STUDY
Para-Aortic Lymph Node Metastasis
The CyberKnife System provided a convenient and minimally invasive treatment option for patients with metastasis to para-aortic lymph nodes.
CASE STUDY
Optic Apparatus Meningioma
Treatment with CyberKnife radiosurgery utilizing a hypofractionated treatment regimen was indicated for maximum local control and to minimize injury to the optic apparatus.
CASE STUDY
Non-Small Cell Lung Cancer – Left Upper Lung
Three months after treatment, the patient reported no evidence of local regional recurrence or treatment-related toxicity.
CASE STUDY
Non-Invasive Treatment of Non-Small Cell Lung Cancer
This patient had an excellent initial outcome with the CyberKnife System using Xsight® Lung Tracking; the patient was able to undergo treatment without implanted fiducials or markers.
CASE STUDY
Left Optic Nerve Meningioma (WHO Grade 2)
Due to the risk of recurrence and intimate association of the lesion with the optic nerve, the CyberKnife® System was selected.
CASE STUDY
C5 Malignant Peripheral Nerve Sheath Tumor
There were no further treatment possibilities as surgery, conventional radiation therapy and chemotherapy were already attempted without preventing tumor growth.
CASE STUDY
T6 Spinal Solitary Breast Metastasis
The treatment of both malignant as well as benign tumors of the spine using CyberKnife radiosurgery began in 1997. Treatment of spine lesions using single fraction radiosurgery has been a successful treatment strategy at UPMC over the past four years.
